Abstract |
The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.
|
Authors | F E Govier, E Jonsson, D Kramer-Levien |
Journal | The Journal of urology
(J Urol)
Vol. 151
Issue 4
Pg. 878-9
(Apr 1994)
ISSN: 0022-5347 [Print] United States |
PMID | 8126815
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Administration, Oral
- Double-Blind Method
- Humans
- Male
- Priapism
(drug therapy)
- Prospective Studies
- Terbutaline
(administration & dosage, therapeutic use)
|